Drugs / OspaVir®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05762523 | May → Jul 2019 | cowpox, monkeypox, smallpox, vaccinia | Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OspaVir | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05762523 ↗ |
| Modality | Vaccine | “inactivated smallpox vaccine OspaVir®” NCT05762523 ↗ |
| Route | Subcutaneous | “vaccination once subcutaneously” NCT05762523 ↗ |